Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- PROCEEDIndependent statistical analysis of Effect of a Patient-Centered Decision App on TOLAC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02646423).
- PROCLAIMIndependent statistical analysis of Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Proclear 1-D Multifocal Nondispensing Study: Complete Statistical AnalysisIndependent statistical analysis of Proclear 1-D Multifocal Nondispensing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01526902).
- PROCLIVITY02Independent statistical analysis of HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01856023).
- PRODIGYIndependent statistical analysis of Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01515748).
- ProDiuSIndependent statistical analysis of Protocolized Diuretic Strategy in Cardiorenal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01921829).
- Product Performance of a New Silicone Hydrogel Contact Lens: Complete Statistical AnalysisIndependent statistical analysis of Product Performance of a New Silicone Hydrogel Contact Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04901897).
- ProFEIBAIndependent statistical analysis of Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PROGIndependent statistical analysis of Progesterone Treatment for Cocaine-dependent Women: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00632099).
- Progesterone for Cannabis Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Progesterone for Cannabis Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03430050).
- Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PROGRESSIndependent statistical analysis of Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors: Complete Statistical AnalysisIndependent statistical analysis of Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03185546).
- Project DRUMIndependent statistical analysis of Developing Rectal USPE Measures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02102867).
- Project Impact: An Innovative Approach to Weight Loss Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Project Impact: An Innovative Approach to Weight Loss Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02363010).
- Project LEAPIndependent statistical analysis of Development and Preliminary Trial of a Brief, Portable Health Intervention for Rural Sexual Minority Emerging Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Project SERVE: Post Deployment Functioning: Complete Statistical AnalysisIndependent statistical analysis of Project SERVE: Post Deployment Functioning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01123642).
- PROLONGIndependent statistical analysis of Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PROLONG-ANG3Independent statistical analysis of A Study of LY3561774 in Participants With Mixed Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256654).
- Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients: Complete Statistical AnalysisIndependent statistical analysis of Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Prolonged Exposure (PE) for Post Traumatic Stress Disorder (PTSD): Telemedicine Versus In Person: Complete Statistical AnalysisIndependent statistical analysis of Prolonged Exposure (PE) for Post Traumatic Stress Disorder (PTSD): Telemedicine Versus In Person: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS): Complete Statistical AnalysisIndependent statistical analysis of Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04581811).
- PROMHIndependent statistical analysis of Proactive Outreach for Smokers in VA Mental Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01737281).
- PROMINENTIndependent statistical analysis of Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PROMIS Measures in Primary Care Practice: Complete Statistical AnalysisIndependent statistical analysis of PROMIS Measures in Primary Care Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02383862).
- PROMISEIndependent statistical analysis of Endoscopic Suturing for Primary Obesity Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01662024).
- PROMISEIndependent statistical analysis of Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PROMISEIndependent statistical analysis of Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROMISEIndependent statistical analysis of Promotion of Successful Parenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03808987).
- Promiseb Topical Cream for Cradle Cap: Complete Statistical AnalysisIndependent statistical analysis of Promiseb Topical Cream for Cradle Cap: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01214434).
- PROMOTE-BC3Independent statistical analysis of Prevention of Malaria in HIV-uninfected Pregnant Women and Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02793622).
- PROMOTE-PEDSIndependent statistical analysis of HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROMOTE-PIsIndependent statistical analysis of Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00993031).
- Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155946).
- Promoting Cervical Cancer Screening for Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Promoting Cervical Cancer Screening for Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03483610).
- Promoting Healthy Lifestyle Behaviors: Complete Statistical AnalysisIndependent statistical analysis of Promoting Healthy Lifestyle Behaviors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05675020).
- Promoting Physical Activity in Churchgoing Latinas: Complete Statistical AnalysisIndependent statistical analysis of Promoting Physical Activity in Churchgoing Latinas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01776632).
- Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children: Complete Statistical AnalysisIndependent statistical analysis of Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Promoting Resilience to Food Commercials Decreases Susceptibility to Unhealthy Food Decision-Making: Complete Statistical AnalysisIndependent statistical analysis of Promoting Resilience to Food Commercials Decreases Susceptibility to Unhealthy Food Decision-Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities: Complete Statistical AnalysisIndependent statistical analysis of Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROMUS Element Plus US Post-Approval Study: Complete Statistical AnalysisIndependent statistical analysis of PROMUS Element Plus US Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01589978).
- Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: Complete Statistical AnalysisIndependent statistical analysis of Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276885).
- PRONOUNCEDIndependent statistical analysis of 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PRONTOIndependent statistical analysis of The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size…
- PRONTO-PBCIndependent statistical analysis of Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRONTO-PumpIndependent statistical analysis of A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes: primary endpoint results, effect estimate with…
- PRONTO-T1DIndependent statistical analysis of A Study of LY900014 in Participants With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03214367).
- Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…